ULTRA-BOND 100 EPOXY RESIN COMP A

Hazard statements (CLP)

H315, H317, H319, H373, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Classification according to GHS

CLP (SI 2019 720 as amended) Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Specific target organ toxicity – Repeated exposure, Category 2 H373 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

May cause damage to organs through prolonged or repeated exposure. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects.

2.2 Label elements

Labelling according to GB CLP (SI 2019:720 as amended)

Hazard pictograms

GB CLP) GHS07 GHS08 GHS09

Signal word

GB CLP) : Warning

Contains

1,6-HEXANDIOLDIGLYCIDYLETHER; FORMALDEHYDE, OLIGOMERIC REACTION PRODUCTS WITH 1-CHLORO-2,3-EPOXYPROPANE AND PHENOL; BIS-[4-(2,3- EPOXIPROPOXI)PHENYL]PROPANE.; QUARTZ (FINE FRACTION)

Hazard statements

GB CLP) : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H373 - May cause damage to organs (lungs) through prolonged or repeated exposure (Inhalation of dust). H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

GB CLP) : P260 - Do not breathe dust, fume, gas, mist, vapours or spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with UK REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in BIS-[4-(2,3-EPOXIPROPOXI)PHENYL]PROPANE.(1675-54-3) accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP